Research has shed light on how a new type of antibody treatment reactivates patients' immune cells to fight ovarian cancer.

Source code for unsupervised differentiation trajectory analysis of myeloid cells in kidney allograft rejection using slingshot, tradeSeq and RightOmicsTools packages from Varin et al. manuscript ...

Apr. 14, 2025 — A groundbreaking open-source computer program uses artificial intelligence to analyze videos of patients with Parkinson's disease and other movement disorders. The tool, called ...

The Lupus Research Alliance (LRA) is proud to announce the recipients of this year's Lupus Innovation Award (LIA), addressing ...

Deciphering the gut biome's, including helminths', influence on human trained immunity will unlock novel immunotherapies harnessing the immune reprogramming potential of their secreted factors and ...

Apr. 9, 2025 — A small protein involved in neurodegeneration leading to Parkinson's disease also drives a type of skin cancer known as melanoma, according to new ... Apr. 7, 2025 — A study ...

Cysts, fibrosis, and tubular degeneration form the typical triad of pathologies leading to the gradual decline in kidney ...

An IgE antibody recognising Folate Receptor-alpha has been tested in clinical trials for ovarian cancer and preclinical studies show macrophage involvement in the anti-tumoural functions of IgE.